Autori: Andric Zoran G
Naslov | Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial (Article) |
Autori | Reck Martin ... Andric Zoran G ... (broj koautora 18) |
Info | JOURNAL OF THORACIC ONCOLOGY, (2024), vol. 19 br. 2, str. 297-313 |
Projekat | Healthcare business of Merck KGaA, Darmstadt, Germany; Pfizer |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study (Article) |
Autori | Leal Ticiana A ... Andric Zoran G ... (broj koautora 25) |
Info | LANCET ONCOLOGY, (2023), vol. 24 br. 9, str. 1002-1017 |
Projekat | Novocure |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro |
Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article) |
Autori | Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce |
Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711 |
Projekat | G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial (Article) |
Autori | Peters Solange ... Andric Zoran G ... (broj koautora 26) |
Info | NATURE MEDICINE, (2022), vol. 28 br. 9, str. 1831-+ |
Projekat | F. Hoffmann-La Roche, Ltd. |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia (Article) |
Autori | Perovic-Blagojevic Iva M Vekic Jelena Z Macut Djuro P Ignjatovic Svetlana D Miljkovic-Trailovic Milica M Zeljkovic Aleksandra R Spasojevic-Kalimanovska Vesna V Bozic-Antic Ivana B Bjekic-Macut Jelica D Kastratovic-Kotlica Biljana A Andric Zoran G Ilic Dusan S Kotur-Stevuljevic Jelena M |
Info | BRITISH JOURNAL OF NUTRITION, (2022), vol. 128 br. 4, str. 604-612 |
Projekat | Serbian Ministry of Science and Education [200110, 451-03-9/2021-14/200161] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article) |
Autori | Weiss Jared Goldschmidt Jerome Andric Zoran G Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey |
Info | CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article) |
Autori | Jassem Jacek ... Andric Zoran G ... (broj koautora 19) |
Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882 |
Projekat | Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Polycystic Ovary Syndrome: A Contemporary Clinical Approach (Review) |
Autori | Bjekic-Macut Jelica D Vukasin Tamara Velija-Asimi Zelija Burekovic Azra Zdravkovic Marija D Andric Zoran G Brankovic Marija S Crevar-Marinovic Slobodanka Madic Tatjana Stanojlovic Olivera P Milutinovic Danijela V Livadas Sarantis Mastorakos George |
Info | CURRENT PHARMACEUTICAL DESIGN, (2021), vol. 27 br. 36, str. 3812-3820 |
Projekat | Ministry of Education, Science and Technological Development, Serbia [451-03-68/2020-14/200007] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid |
Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
Projekat | Centus Biotherapeutics |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|